BioSpace News Archive

Just like a fingerprint, each person’s hearing is unique. Yet, the most commonly worn hearing aids use a standardized approach modeled on an ‘average ear’, which can often compromise sound quality.

Avacta Group plc, the developer of Affimer® biotherapeutics and reagents, is pleased to announce the expansion of its existing multi-target collaboration and development agreement with LG Chem Life Sciences, the life sciences division of the South Korean LG Group, to include new programmes incorporating Avacta’s Affimer XT™ serum half-life extension system.

First biologic approved in Canada for adults with severe chronic rhinosinusitis with nasal polyposis (CRSwNP)

Trinity Biotech plc (Nasdaq: TRIB), a leading developer and manufacturer of diagnostic products for the point-of-care and clinical laboratory markets, will report financial results for the second quarter 2020 on Tuesday, August 25, 2020. The Company has scheduled a conference call for that same day, Tuesday, August 25, 2020 at 11:00am ET (4:00pm BST) to discuss the results of the quarter. Interested parties can access the call by dialing:

Agilent Technologies Inc. (NYSE: A) today announced it will expand its state-of-the-art production facility in Frederick, Colorado, that develops and manufactures “oligos,” which are short DNA and RNA molecules used to create nucleic acid-based therapeutics.

Ernst & Young LLP (EY US) today announced that Daniel Pontecorvo of Camber Spine Technologies was named an Entrepreneur Of The Year® 2020 Greater Philadelphia Award finalist.

MedShape, Inc., the industry leader in innovative NiTiNOL and other advanced material technologies, today announced that it has received a Technology/Therapeutic Development Award funded by the Department of Defense Peer Reviewed Medical Research Program (PRMRP)

GT Medical Technologies, Inc., a company dedicated to improving the lives of patients with brain tumors, today announced new data from a clinical study of the company’s GammaTile® Therapy in patients with large brain metastases, or tumors that spread to the brain from cancer in another part of the body.

Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced its interim results for the six months ended June 30, 2020 . During the reporting period, Ascentage Pharma m

Chinook Therapeutics, Inc., a privately held clinical-stage biotechnology company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced a $106 million private placement financing,